FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors. - Wikidata - awgldk - TriplyDB

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q37504931

about

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.The Call of "The Wild"-Type GIST: It's Time for Domestication.SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.Emerging drugs for the treatment of gastrointestinal stromal tumour.Latest advances in adult gastrointestinal stromal tumors.Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.What is New in Gastrointestinal Stromal Tumor?A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy.Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece.Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers.

P2860

Q33722723-15FF5E0E-8180-4CB0-BF49-1C1C87A644FD Q38671477-D20EDABB-F94A-4EB3-8AFF-54371515A9AE Q39186932-81597CA6-AB03-4384-A2ED-607E42C7BD59 Q41325497-44D07C84-C5B3-4405-9FCD-10AC80DAC76D Q46498642-379F51B7-E232-4C6C-ADC0-9974DA351CCD Q47355982-0AE2BC62-68CE-4FF7-BF00-FE38EC729978 Q47912361-5F3E2984-FC9C-483D-93E7-811806D75FBB Q48141393-82593B6B-5680-4DC5-8BEE-2FB0F4CC4FF9 Q50575961-A19D90B3-3F5E-4ADB-AB05-D29C14F90C63 Q52663678-07572940-1AEA-4C74-8249-A58D8D5BC1B7 Q54116611-5CABAE42-F4A5-4D1C-8ED9-0D7CB326EBBF Q55275497-B02013EE-ECD5-4A37-8227-9233E27A7412 Q55424463-613D0E2A-F1D8-4176-AE76-35F01DDDDDC0

P2860

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q37504931

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@en

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@nl

type

label

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@en

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@nl

prefLabel

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@en

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@nl

P1433

Q37504931-B47A5639-9909-4BDB-8F29-0C7231FFB4BE

P1476

Q37504931-91DDD42D-F28C-40EA-A9A6-8584FE421862

P2093

Q37504931-09143183-7534-417B-876E-8849C35E5972

Q37504931-0A29B913-8028-41C6-BB84-F488C4D9A445

Q37504931-0A86B09E-3F0A-42E0-B69C-352E3E550894

Q37504931-109921EA-3755-448C-A5E8-7166F72C78AA

Q37504931-131DC483-010A-4544-B6D9-4C4A43DE8AA8

Q37504931-1A5A2D1F-09FF-45FA-8612-18D1A94EC28B

Q37504931-1B99AD5C-F9DB-4BEA-ADF5-F3DCD613A50B

Q37504931-2B9231D2-0AA1-457D-A74A-D2D2818D20CA

Q37504931-30A549C2-D81E-4896-97DC-3533266C22A1

Q37504931-5464D926-014A-4D85-900F-AB1070BB9E29

P2860

Q37504931-04978D6D-A219-44A7-8F51-9008CD97AD0A

Q37504931-08BDD43B-5BE6-4A6D-9D39-7E4D1119FC09

Q37504931-09933C62-8D81-4AED-B22E-671C43489F09

Q37504931-0A10735B-1E90-4DC6-BF25-F505B6B33113

Q37504931-0AA870BC-7E8C-4BEB-B9EB-5BCDC84864CF

Q37504931-0D4AB6F6-9748-4518-AA5B-A5ECAE303A6D

Q37504931-15C950BC-7B48-4909-83E7-40A93095FF98

Q37504931-1957557F-6B40-4B7B-9BCC-433A1800D7D1

Q37504931-2BACE145-6812-4F77-8FB4-B6F6E79CE85E

Q37504931-2D98CD1F-4BF1-4BFC-92C6-42B311A15BBE

P2888

Q37504931-29B0F642-5399-4CE0-B907-726C3994A49C

P304

Q37504931-8D6DE404-42FA-44C3-9379-3EA3A3D2058E

P31

Q37504931-80406354-7A7A-4987-A78C-BC55C628964C

P356

Q37504931-9DEAE208-6566-4E11-8DF4-2EE239C00480

P433

Q37504931-09BEAF48-FDF1-47F2-AF4D-2DD7E66C3CBE

P478

Q37504931-AA08C457-BCB2-41E2-9AC5-D53E8C7E4F32

P50

Q37504931-8C0CE00A-6847-43AD-80C0-13BB700CD27F

Q37504931-9E6B0A31-B179-4735-A29D-C11EFF7D2B2D

Q37504931-F6D744F1-62ED-4334-BF54-DF16C65AC963

P577

Q37504931-74B137F4-2358-4911-BE09-0FFE695BBABD

P6179

Q37504931-BAC4BD98-F259-4E2F-954E-0883E905AD07

P698

Q37504931-53DBB6F3-8158-42E5-B2A8-D0B0F7B68FB4

P932

Q37504931-FF5EA96F-45AB-4320-9B30-7FD7BA1AD652

P356

S12967-016-1075-6

P1433

Journal of Translational Medicine

P1476

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

@en

P2093

Adam M Burgoyne

http://www.w3.org/2001/XMLSchema#string

Chih-Min Tang

http://www.w3.org/2001/XMLSchema#string

Christopher L Corless

http://www.w3.org/2001/XMLSchema#string

David Hong

http://www.w3.org/2001/XMLSchema#string

Deborah Morosini

http://www.w3.org/2001/XMLSchema#string

Eileen Shi

http://www.w3.org/2001/XMLSchema#string

Gregory M Heestand

http://www.w3.org/2001/XMLSchema#string

Guhyun Kang

http://www.w3.org/2001/XMLSchema#string

James D Murphy

http://www.w3.org/2001/XMLSchema#string

Jason K Sicklick

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines

BCoR, a novel corepressor involved in BCL-6 repression

Receptor specificity of the fibroblast growth factor family

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

Analysis of protein-coding genetic variation in 60,706 humans

Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain Dimer

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

Identification of targetable FGFR gene fusions in diverse cancers.

LRP: a multifunctional scavenger and signaling receptor

P2888

s12967-016-1075-6

P304

339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-016-1075-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Razelle Kurzrock

Olivier Harismendy

Juliann Chmielecki

P577

2016-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046889290

http://www.w3.org/2001/XMLSchema#string

P698

27974047

http://www.w3.org/2001/XMLSchema#string

P932

5157084

http://www.w3.org/2001/XMLSchema#string